Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centre

@inproceedings{Syed2011LongtermCO,
  title={Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centre},
  author={Binafsha Manzoor Syed and Waleed Al-Khyatt and Shaida Johnston and Duane W Wong and Linda Winterbottom and HARVEYE. KENNEDY and Andrew R. Green and Daniel Morgan and I O Ellis and Kwok Leung Cheung},
  booktitle={British Journal of Cancer},
  year={2011}
}
Introduction:A Cochrane review of seven randomised trials (N=1571) comparing surgery and primary endocrine therapy (PET) (oestrogen receptor (ER) unselected) shows no difference in overall survival (OS). We report outcome of a large series with ER-positive (ER+) early invasive primary breast cancer.Methods:Between 1973 and 2009, 1065 older (⩾70 years) women (median age 78 years (70–99)) had either surgery (N=449) or PET (N=616) as initial treatment.Results:At 49-month median follow-up (longest… CONTINUE READING
7 Citations
26 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 26 references

Investigation of primary tamoxifen therapy for elderly patients with operable

  • P Willsher, J Robertson, L Jackson, M Hilaly, R Blamey
  • BREAST
  • 1997
Highly Influential
4 Excerpts

Investigation of primary tamoxifen therapy for elderly patients with operable breast cancer

  • P Willsher, J Robertson, L Jackson, M Hilaly, R Blamey
  • Breast 6:
  • 1997
Highly Influential
4 Excerpts

The design and clinical use of the Nottingham Prognostic Index in breast cancer

  • R Blamey
  • Breast 5:
  • 1996
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…